Top compounds associated with response to SLC11A2


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.012 0.7
mRNA KIN001-236 GDSC1000 pan-cancer AAC -0.011 0.7
mRNA KIN001-055 GDSC1000 pan-cancer AAC -0.011 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.011 0.7
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA bendamustine CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Cytarabine FIMM pan-cancer AAC 0.058 0.7
Download CSV